DRUG dividend yield: 4.00%. ARCC dividend yield: 9.06%. DRUG is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DRUG shares. Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.
DRUG is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DRUG shares.
Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.
Is DRUG or ARCC better for dividend income in 2026?
DRUG currently offers a 4.00% yield (2.00/share/year) while ARCC offers 9.06% (1.92/share/year). ARCC provides higher current income. However, DRUG has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in DRUG vs ARCC earn per year?
With $10,000 invested today: DRUG pays approximately $400/year. ARCC pays approximately $906/year. With DRIP reinvestment over 10 years, these grow to $899/year (DRUG) and $2,279/year (ARCC).
Does DRUG or ARCC pay monthly dividends?
DRUG pays quarterly dividends. ARCC pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this DRUG vs ARCC comparison by email
Save your analysis + get weekly dividend insights. Free forever.